TitleComparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids.
Publication TypeJournal Article
Year of Publication2001
AuthorsCarr AC, Decker EA, Park Y, Frei B
JournalFree Radic Biol Med
Date Published2001 Jul 01
KeywordsApolipoproteins B, Ascorbic Acid, Bromates, Humans, Hydrogen Peroxide, Hypochlorous Acid, Leukocytes, Lipid Peroxidation, Lipoproteins, LDL

Myeloperoxidase (MPO), a heme enzyme secreted by activated phagocytes, catalyzes the oxidation of halides to hypohalous acids. At plasma concentrations of halides, hypochlorous acid (HOCl) is the major strong oxidant produced. In contrast, the related enzyme eosinophil peroxidase preferentially generates hypobromous acid (HOBr). Since reagent and MPO-derived HOCl converts low-density lipoprotein (LDL) to a potentially atherogenic form, we investigated the effects of HOBr on LDL modification. Compared to HOCl, HOBr caused 2-3-fold greater oxidation of tryptophan and cysteine residues of the protein moiety (apoB) of LDL and 4-fold greater formation of fatty acid halohydrins from the lipids in LDL. In contrast, HOBr was 2-fold less reactive than HOCl with lysine residues and caused little formation of N-bromamines. Nevertheless, HOBr caused an equivalent increase in the relative electrophoretic mobility of LDL as HOCl, which was not reversed upon subsequent incubation with ascorbate, in contrast to the shift in mobility caused by HOCl. Similar apoB modifications were observed with HOBr generated by MPO/H(2)O(2)/Br(-). In the presence of equivalent concentrations of Cl(-) and Br(-), modifications of LDL by MPO resembled those seen in the presence of Br(-) alone. Interestingly, even at physiological concentrations of the two halides (100 mM Cl(-), 100 microM Br(-)), MPO utilized a portion of the Br(-) to oxidize apoB cysteine residues. MPO also utilized the pseudohalide thiocyanate to oxidize apoB cysteine residues. Our data show that even though HOBr has different reactivities than HOCl with apoB, it is able to alter the charge of LDL, converting it into a potentially atherogenic particle.

Alternate JournalFree Radic. Biol. Med.
PubMed ID11425491
Grant ListAT-00066 / AT / NCCIH NIH HHS / United States
HL-56170 / HL / NHLBI NIH HHS / United States